Search Results - "Hunault, Mathilde"

Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML.

Authors: Gyan, Emmanuel Pigneux, Arnaud Hunault, Mathilde et al.

Source: Scientific Reports. 6/13/2022, Vol. 12 Issue 1, p1-9. 9p.

Intensive Therapy before or during the Conditioning Regimen of Allogeneic Marrow Transplantation in Adult Acute Lymphoblastic Leukemia Patients: We Must Choose to Reduce Toxicity—A Groupe Ouest-Est d’Etude des Leucémies et Autres Maladies du Sang Study

Authors: Deconinck, Eric Hunault, Mathilde Milpied, Noël et al.

Source: Biology of Blood & Marrow Transplantation. Jun2005, Vol. 11 Issue 6, p448-454. 7p.

Feasibility of tooth brushing during prolonged neutropenia in adults receiving intensive induction for acute leukemia: a randomized trial.

Authors: Valette, Amandine Moreau, Clémence Marie, Céline et al.

Source: Supportive Care in Cancer. Jul2026, Vol. 34 Issue 7, p1-8. 8p.

New insights in the treatment of patients with solitary bone plasmacytoma.

Authors: Mheidly, Kayane Lamy De La Chapelle, Thierry Hunault, Mathilde et al.

Source: Leukemia & Lymphoma. Nov2019, Vol. 60 Issue 11, p2810-2813. 4p.

Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.

Authors: Laloi, Louise Billotey, Natacha Chaumard Dumas, Pierre‐Yves et al.

Source: Cancer Medicine. Mar2023, Vol. 12 Issue 6, p7175-7181. 7p.

Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.

Authors: Boudry, Augustin Darmon, Sasha Duployez, Nicolas et al.

Source: BMC Bioinformatics. 12/9/2022, Vol. 23 Issue 1, p1-16. 16p.

Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post‐transplant cyclophosphamide.

Authors: Jullien, Maxime Orvain, Corentin Berceanu, Ana et al.

Source: Cancer Medicine. Oct2021, Vol. 10 Issue 20, p7194-7202. 9p.

Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations.

Authors: Lacombe, Valentin Nunes Gomes, Christopher Robin, Jean‐Baptiste et al.

Source: European Journal of Haematology. Oct2021, Vol. 107 Issue 4, p489-496. 8p.

Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status.

Authors: Jouzier, Claire Hamel, Jean‐François Dumas, Pierre‐Yves et al.

Source: European Journal of Haematology. Jun2021, Vol. 106 Issue 6, p859-867. 9p.

Pairing MCL‐1 inhibition with venetoclax improves therapeutic efficiency of BH3‐mimetics in AML.

Authors: Hormi, Myriam Birsen, Rudy Belhadj, Maya et al.

Source: European Journal of Haematology. Nov2020, Vol. 105 Issue 5, p588-596. 9p.

Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia.

Authors: Lafage-Pochitaloff, Marina Baranger, Laurence Hunault, Mathilde et al.

Source: Blood. 10/19/2017, Vol. 130 Issue 16, p1832-1844. 13p.

Outcome of Ph negative myeloproliferative neoplasms transforming to accelerated or leukemic phase.

Authors: Mollard, Lise-Marie Chauveau, Aurélie Boyer-Perrard, Françoise et al.

Source: Leukemia & Lymphoma. Dec2018, Vol. 59 Issue 12, p2812-2820. 9p.

Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.

Authors: Brousseau, Maud Parot-Schinkel, Elsa Moles, Marie-Pierre et al.

Source: Histopathology. May2010, Vol. 56 Issue 6, p758-767. 10p. 2 Color Photographs, 1 Black and White Photograph, 4 Charts.

Next generation sequencing redefines a triple negative essential thrombocythaemia as double‐positive with rare mutations on JAK2 V617 and MPL W515 hotspots.

Authors: Beucher, Annaëlle Dib, Mammoun Orvain, Corentin et al.

Source: British Journal of Haematology. Sep2019, Vol. 186 Issue 5, p785-788. 4p. 1 Diagram, 1 Chart.

Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.

Authors: Maury, Sébastien Chevret, Sylvie Thomas, Xavier et al.

Source: New England Journal of Medicine. 9/15/2016, Vol. 375 Issue 11, p1044-1053. 10p.

Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL.

Authors: Rousselot, Philippe Coudé, Marie Magdelaine Gokbuget, Nicola et al.

Source: Blood. 8/11/2016, Vol. 128 Issue 6, p774-782. 9p.

A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure.

Authors: Thepot, Sylvain Boehrer, Simone Seegers, Valérie et al.

Source: Leukemia Research. Dec2014, Vol. 38 Issue 12, p1430-1434. 5p.

Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.

Authors: Lioure, Bruno Béné, Marie C. Pigneux, Arnaud et al.

Source: Blood. 3/22/2012, Vol. 119 Issue 12, p2943-2948. 6p.

Epidemiology and Risk Factors for Gram-Positive Coccal Infections in Neutropenia: Toward a More Targeted Antibiotic Strategy.

Authors: Cordonnier, Catherina Buzyn, Agnes Leverger, Guy et al.

Source: Clinical Infectious Diseases. 1/15/2003, Vol. 36 Issue 2, p149-158. 10p.

To the editor: Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia.

Authors: Wanquet, Anne Birsen, Rudy Lemal, Richard et al.

Source: Blood. 5/12/2016, Vol. 127 Issue 19, p2356-2358. 3p.